Ingredion vs McCormick
INGR and MKC side by side, both in food and kindred products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INGR and MKC compare
McCormick is the larger company, worth 2.1 times as much as Ingredion ($12.7B against $6.1B).
On earnings, McCormick is cheaper: it trades at 8.6× trailing earnings, against 10.6× for Ingredion.
McCormick grew revenue faster over the last twelve months (13.2% versus −1.4% for Ingredion).
McCormick keeps more of each dollar of sales as profit, with a net margin of 19.4% compared with 8.2% at Ingredion.
Both pay dividends: Ingredion yields 3.4% and McCormick 4.1%.
McCormick scores higher on the StockData Score (21 against 20 for Ingredion), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INGR | MKC |
|---|---|---|
| Size and price | ||
| Market cap | $6.1B | $12.7B |
| Share price | $96.97 | $47.29 |
| Change, 1 year | −16.2% | −25.9% |
| Change, 5 years | −1.3% | −41.8% |
| Beta (5Y) | 0.39 | 0.41 |
| Employees | 11K | 14K |
| StockData Score | ||
| Total score | 20 | 21 (better) |
| Valuation score | 6 | 6 |
| Growth score | 1 | 3 (better) |
| Performance score | 5 | 5 |
| Health score | 5 (better) | 2 |
| Dividend score | 3 | 5 (better) |
| Valuation | ||
| P/E | 10.6× | 8.6× (better) |
| P/S | 0.8× (better) | 1.7× |
| P/B | 1.4× (better) | 1.8× |
| EV/EBITDA | 6.4× (better) | 13.8× |
| P/FCF | 17.2× | 13.7× (better) |
| PEG | 0.70 (better) | 1.66 |
| FCF yield | 5.8% | 7.3% (better) |
| Fair value | $166.58 | $90.06 |
| Margin of safety | 41.8% | 47.5% (better) |
| Growth | ||
| Revenue growth (TTM) | −1.4% | 13.2% (better) |
| Revenue growth, 5Y average | 3.8% | 4.1% (better) |
| Net income growth (TTM) | −12.4% | 91.6% (better) |
| EPS growth (TTM) | −10.5% | 91.3% (better) |
| EPS growth, 5Y average | 16.8% (better) | 1.1% |
| Profitability | ||
| Gross margin | 23.7% | 39.1% (better) |
| Operating margin | 11.9% | 13.4% (better) |
| Net margin | 8.2% | 19.4% (better) |
| FCF margin | 4.9% | 12.0% (better) |
| Return on equity | 13.6% | 23.4% (better) |
| Return on invested capital | 12.0% (better) | 6.9% |
| Financial health | ||
| Debt / equity | 0.39 (better) | 0.72 |
| Net debt / EBITDA | 0.77 (better) | 3.59 |
| Interest coverage | – | 4.6× |
| Current ratio | 2.80 (better) | 0.66 |
| Altman Z-score | 3.63 (better) | 1.80 |
| Piotroski F-score | 8 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 3.4% | 4.1% (better) |
| Payout ratio | 35.5% | 34.1% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 7.7% |
| Buyback yield | – | 0.13% |
| Shareholder yield | 3.4% | 4.2% (better) |
| Ownership | ||
| Held by institutions | 98.9% | 89.8% |
| Held by insiders | 0.81% | 1.1% |
| Insider net buying, 12 months | −$6.0M (better) | −$24.9M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 7.7% | – |
Go deeper
- INGR stock overview
- INGR income statement
- INGR valuation and score
- MKC stock overview
- MKC income statement
- MKC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.